Fresenius Kabi and Baxter Healthcare Corp. will supply $16 million in vital ICU drugs to the national medical stockpile to bolster supplies for hospitals battling Covid-19.
The Strategic National Stockpile, a national repository of emergency medical supplies, is purchasing “critically needed ICU medications as part of the Covid-19 response” from Fresenius Kabi and Baxter Healthcare Corp. Fresenius was awarded a contract worth $12.5 million, and Baxter was awarded a contract worth $3.6 million.
Hospitals have struggled to get needed drugs during the pandemic and are looking at creating their own stockpiles of the medications.
The Department of Health and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.